The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery
Launched by DOGUS UNIVERSITESI · Aug 9, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether certain techniques, known as neurophysiological facilitation, can help improve breathing and overall physical ability in patients who have just had open heart surgery. The researchers want to find out if these techniques work better than standard early rehabilitation, which is also being given to both groups in the study.
To participate in this trial, you need to be between 18 to 75 years old and must have had open heart surgery for the first time. However, if you have certain conditions, like fractures, kidney issues, or a history of strokes, you may not be eligible. If you join the study, you can expect to receive care focused on helping you recover after surgery, including exercises and support to improve your health. This trial is currently looking for participants, and it aims to provide valuable information that could help improve recovery for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having open heart surgery for the first time,
- • Being between the ages of 18-75,
- • Being fully cooperative
- Exclusion Criteria:
- • Having facial, sternum and rib fractures,
- • Having chronic renal failure,
- • Development of cerebrovascular accident,
- • Having cognitive dysfunction,
- • Development of deep vein thrombosis in the post-operative period,
- • Having neuromuscular disease,
- • Having an orthopedic disability,
- • Intubation time longer than 24 hours,
- • Staying in intensive care for more than 48 hours
About Dogus Universitesi
Dogus Universitesi is a leading academic institution in Turkey dedicated to advancing research and education in various fields, including clinical sciences. As a clinical trial sponsor, the university is committed to fostering innovation and improving healthcare outcomes through rigorous scientific investigation. Leveraging its strong academic resources and collaborative environment, Dogus Universitesi aims to facilitate the development of new therapies and interventions, ensuring adherence to ethical standards and regulatory requirements. The university's focus on interdisciplinary research and partnership with healthcare professionals positions it as a key player in the advancement of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Yasemin Cirak, Prof. Dr.
Principal Investigator
Istinye University
Feyza merakli
Study Director
Istinye University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported